We are live on
!
Find out more
PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Est. Return
26.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.82%
1 Year Est. Return
+26.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$80B
AUM Growth
+$10.8B
(+16%)
Cap. Flow
+$3.26B
Cap. Flow
% of AUM
4.07%
Top 10 Holdings %
Top 10 Hldgs %
14.5%
Holding
2,075
New
91
Increased
698
Reduced
631
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$261M |
| 2 |
Trane Technologies
TT
|
+$209M |
| 3 |
Visa
V
|
+$204M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$171M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revvity
RVTY
|
+$150M |
| 2 |
PayPal
PYPL
|
+$149M |
| 3 |
Lam Research
LRCX
|
+$135M |
| 4 |
EA
Electronic Arts
EA
|
+$132M |
| 5 |
Waste Management
WM
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.21% |
| 2 | Healthcare | 16.75% |
| 3 | Industrials | 14.95% |
| 4 | Utilities | 9.88% |
| 5 | Consumer Discretionary | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Becton Dickinson
BDX
$50.3B
| $29.8M | 0.04% |
120,544
+2,604
| +2% | +$637K |
|
|
APLS
377
DELISTED
Apellis Pharmaceuticals
APLS
| $29.7M | 0.04% |
450,039
+4,334
| +1% | +$250K |
|
378
Equity Residential
EQR
$24.8B
| $29.7M | 0.04% |
494,348
-70,792
| -13% | -$4.35M |
|
379
Motorola Solutions
MSI
$77.4B
| $29.4M | 0.04% |
102,741
+24,505
| +31% | +$6.47M |
|
380
Denali Therapeutics
DNLI
$4.03B
| $28.8M | 0.04% |
1,248,490
+77,134
| +7% | +$2.12M |
|
381
Sun Life Financial
SLF
$44.8B
| $28.5M | 0.04% |
610,802
-53,575
| -8% | -$2.58M |
|
382
Intercontinental Exchange
ICE
$85.6B
| $28.3M | 0.04% |
271,601
-3,079
| -1% | -$321K |
|
|
VMW
383
DELISTED
VMware, Inc
VMW
| $28.3M | 0.04% |
226,709
-19,117
| -8% | -$2.3M |
|
|
ATVI
384
DELISTED
Activision Blizzard
ATVI
| $28.2M | 0.04% |
329,674
-200,233
| -38% | -$15.6M |
|
385
Ingersoll Rand
IR
$32.5B
| $28.2M | 0.04% |
484,944
+287,339
| +145% | +$16.2M |
|
386
HCA Healthcare
HCA
$88.8B
| $28.2M | 0.04% |
106,889
-4,410
| -4% | -$1.12M |
|
|
SWTX
387
DELISTED
SpringWorks Therapeutics
SWTX
| $28.1M | 0.04% |
1,093,350
+6,783
| +0.6% | +$198K |
|
388
Celldex Therapeutics
CLDX
$3.47B
| $28.1M | 0.04% |
+779,628
| New | +$33.6M |
|
389
General Mills
GIS
$20.8B
| $27.8M | 0.03% |
325,040
-7,218
| -2% | -$576K |
|
390
Expeditors International
EXPD
$24.1B
| $27.4M | 0.03% |
248,657
+25,947
| +12% | +$2.82M |
|
391
Shopify
SHOP
$198B
| $27.3M | 0.03% |
569,647
-1,049,038
| -65% | -$46.2M |
|
|
KDNY
392
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $27.2M | 0.03% |
1,174,756
+8,592
| +0.7% | +$205K |
|
|
RXDX
393
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $27M | 0.03% |
251,806
+248,839
| +8,387% | +$28.6M |
|
394
Newmont
NEM
$121B
| $26.9M | 0.03% |
548,808
+160,930
| +41% | +$7.8M |
|
395
Valero Energy
VLO
$94.4B
| $26.8M | 0.03% |
191,765
-19,279
| -9% | -$2.59M |
|
396
Viridian Therapeutics
VRDN
$2.55B
| $26.5M | 0.03% |
+1,042,965
| New | +$33.4M |
|
397
Zoom
ZM
$31.1B
| $26.5M | 0.03% |
358,658
-207,953
| -37% | -$15M |
|
398
Labcorp
LH
$26.2B
| $26.4M | 0.03% |
133,902
-10,872
| -8% | -$2.24M |
|
399
Sherwin-Williams
SHW
$87.9B
| $26.3M | 0.03% |
117,136
+1,578
| +1% | +$361K |
|
400
Novanta
NOVT
$6.35B
| $26.1M | 0.03% |
164,302
-13,953
| -8% | -$2.14M |
|
Similar funds
TF
TAIM
V
PI
WI
VIA
EST
TCM
Pictet Asset Management (Switzerland)'s Q1 2023 Portfolio in Review
As of Q1 2023, Pictet Asset Management (Switzerland) held 2,075 positions worth $80B, up 16% from $69.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Pictet Asset Management (Switzerland) deployed $3.26B of net new capital in Q1 2023, opening 91 new positions and adding to 698 existing holdings. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 603,000 shares worth $52M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Revvity, an estimated $150M trimmed.
- Pictet Asset Management (Switzerland)'s largest Q1 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 603,000 shares worth $52M.
- Pictet Asset Management (Switzerland) added most to Microsoft in Q1 2023, an estimated $261M increase.
- Pictet Asset Management (Switzerland)'s biggest Q1 2023 reduction was Revvity, cutting an estimated $150M.
- Pictet Asset Management (Switzerland) fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $52.4M.
- Pictet Asset Management (Switzerland)'s ten largest holdings make up 15% of its $80B portfolio in Q1 2023.
- Pictet Asset Management (Switzerland) opened 91 new positions and closed 99 in Q1 2023.
- Pictet Asset Management (Switzerland)'s portfolio value rose 16% quarter-over-quarter to $80B.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 10 May 2023.